Mathias Svahn

Chairman & CEO

C-suiteM

FI·FIN-FSA

NextCell Pharma AB NextCell Pharma AB

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Browse the complete record of transactions filed by Mathias Svahn, Chairman & CEO. Insider active across 2 companies, notably NextCell Pharma AB. In total, 4 reports have been published. The latest transaction was disclosed on 30 May 2025 — Other. Regulator: FIN-FSA. The full history is accessible without signup.

Declarations4 total

Executives●OtherNNextCell Pharma AB24FIN-FSA

M

Mathias SvahnVerkställande direktör (VD)

€5,78862,894 shares@ €0.0920.0049% mcap12.2% of flow

Aktie

FI:A003P238-2·30 May 2025

FIN-FSA ↗

Executives●OtherNNextCell Pharma AB23FIN-FSA

M

Mathias SvahnVerkställande direktör (VD)

062,894 shares0

Option

FI:A003P257-1·30 May 2025

FIN-FSA ↗

Executives●OtherNNextCell Pharma AB23FIN-FSA

M

Mathias SvahnVerkställande direktör (VD)

0454,019 shares0

Option

FI:A003P256-1·30 May 2025

FIN-FSA ↗

Executives●OtherNNextCell Pharma AB35FIN-FSA

M

Mathias SvahnVerkställande direktör (VD)

€41,780454,019 shares@ €0.0920.035% mcap87.8% of flow

Aktie

FI:A003P236-2·30 May 2025

FIN-FSA ↗

4 of 4 declarations

About Mathias Svahn

Mathias Svahn is the CEO of NextCell Pharma AB. He is responsible for the daily management of the company and the implementation of its strategy. His expertise in the pharmaceutical sector is essential for NextCell's development.